Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein.

PubWeight™: 2.82‹?› | Rank: Top 1%

🔗 View Article (PMC 23478)

Published in Proc Natl Acad Sci U S A on September 30, 1997

Authors

P Dhordain1, O Albagli, R J Lin, S Ansieau, S Quief, A Leutz, J P Kerckaert, R M Evans, D Leprince

Author Affiliations

1: U124 Institut National de la Santé et de la Recherche Médicale, Institut de Recherches sur le Cancer de Lille Place de Verdun, F-59045 Lille Cedex France. dhordain@infobiogen.fr

Articles citing this

Repression domains of class II ERF transcriptional repressors share an essential motif for active repression. Plant Cell (2001) 4.19

Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Genes Dev (2000) 4.00

Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation. Nat Immunol (2010) 3.48

New and emerging HDAC inhibitors for cancer treatment. J Clin Invest (2014) 3.35

The catenin p120(ctn) interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol Cell Biol (1999) 3.02

Polycomb group and SCF ubiquitin ligases are found in a novel BCOR complex that is recruited to BCL6 targets. Mol Cell Biol (2006) 2.99

BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev (2000) 2.83

Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc Natl Acad Sci U S A (1998) 2.55

The biology of human lymphoid malignancies revealed by gene expression profiling. Adv Immunol (2005) 2.42

TGF-β and retinoic acid induce the microRNA miR-10a, which targets Bcl-6 and constrains the plasticity of helper T cells. Nat Immunol (2012) 2.37

Co-operative DNA binding by GAGA transcription factor requires the conserved BTB/POZ domain and reorganizes promoter topology. EMBO J (1999) 2.32

Bcl-6 and NF-kappaB cistromes mediate opposing regulation of the innate immune response. Genes Dev (2010) 2.31

Identification of Bach2 as a B-cell-specific partner for small maf proteins that negatively regulate the immunoglobulin heavy chain gene 3' enhancer. EMBO J (1998) 2.13

Instruction for cytokine expression in T helper lymphocytes in relation to proliferation and cell cycle progression. J Exp Med (1999) 2.09

The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides. Nucleic Acids Res (2002) 2.02

Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia. J Clin Invest (2001) 2.00

Transcriptional repression of Stat6-dependent interleukin-4-induced genes by BCL-6: specific regulation of iepsilon transcription and immunoglobulin E switching. Mol Cell Biol (1999) 1.91

Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation. EMBO J (1999) 1.76

A role for the GSG domain in localizing Sam68 to novel nuclear structures in cancer cell lines. Mol Biol Cell (1999) 1.76

Transcriptional repression by the insulator protein CTCF involves histone deacetylases. Nucleic Acids Res (2000) 1.74

Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors. Mol Cell Biol (2002) 1.70

An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity. Mol Cell Biol (2007) 1.69

JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2). Mol Cell Biol (2005) 1.67

In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions. Mol Cell Biol (2000) 1.66

Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells. Blood (2009) 1.64

BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. Proc Natl Acad Sci U S A (2009) 1.62

Identification of mammalian Sds3 as an integral component of the Sin3/histone deacetylase corepressor complex. Mol Cell Biol (2002) 1.56

The zinc finger transcription factor Zbtb7b represses CD8-lineage gene expression in peripheral CD4+ T cells. Immunity (2008) 1.55

Transcriptional repression by the SMRT-mSin3 corepressor: multiple interactions, multiple mechanisms, and a potential role for TFIIB. Mol Cell Biol (1998) 1.51

Structure of a BCOR corepressor peptide in complex with the BCL6 BTB domain dimer. Mol Cell (2008) 1.46

The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis. Proc Natl Acad Sci U S A (2002) 1.43

CtBP is an essential corepressor for BCL6 autoregulation. Mol Cell Biol (2008) 1.41

Functional interaction of STAT5 and nuclear receptor co-repressor SMRT: implications in negative regulation of STAT5-dependent transcription. EMBO J (2001) 1.39

The corepressor N-CoR and its variants RIP13a and RIP13Delta1 directly interact with the basal transcription factors TFIIB, TAFII32 and TAFII70. Nucleic Acids Res (1998) 1.39

Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B. Proc Natl Acad Sci U S A (1999) 1.37

The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif. Mol Cell Biol (2002) 1.34

Lineage-specific functions of Bcl-6 in immunity and inflammation are mediated by distinct biochemical mechanisms. Nat Immunol (2013) 1.30

Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas. Proc Natl Acad Sci U S A (2002) 1.30

BAZF, a novel Bcl6 homolog, functions as a transcriptional repressor. Mol Cell Biol (1998) 1.29

Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4. J Exp Med (1999) 1.29

mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor. Mol Cell Biol (2000) 1.24

Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1. J Biol Chem (2009) 1.18

Transcriptional silencing is defined by isoform- and heterodimer-specific interactions between nuclear hormone receptors and corepressors. Mol Cell Biol (1998) 1.16

POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function. Immunol Rev (2012) 1.14

The N-terminal BTB/POZ domain and C-terminal sequences are essential for Tramtrack69 to specify cell fate in the developing Drosophila eye. Genetics (2000) 1.14

FBI-1 can stimulate HIV-1 Tat activity and is targeted to a novel subnuclear domain that includes the Tat-P-TEFb-containing nuclear speckles. Mol Biol Cell (2002) 1.14

Functional studies of the BTB domain in the Drosophila GAGA and Mod(mdg4) proteins. Nucleic Acids Res (2000) 1.09

RARalpha-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia. Proc Natl Acad Sci U S A (2007) 1.09

Follicular helper T cells: new insights into mechanisms of autoimmune diseases. Ochsner J (2013) 1.08

ZBTB2, a novel master regulator of the p53 pathway. J Biol Chem (2009) 1.06

Vitamin A and retinoic acid in the regulation of B-cell development and antibody production. Vitam Horm (2011) 1.04

Identification of PCIF1, a POZ domain protein that inhibits PDX-1 (MODY4) transcriptional activity. Mol Cell Biol (2004) 1.04

Transcriptional anti-repression. Thyroid hormone receptor beta-2 recruits SMRT corepressor but interferes with subsequent assembly of a functional corepressor complex. J Biol Chem (1999) 1.02

Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor. Mol Endocrinol (1998) 1.00

batman Interacts with polycomb and trithorax group genes and encodes a BTB/POZ protein that is included in a complex containing GAGA factor. Mol Cell Biol (2003) 0.99

Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor. EMBO J (1999) 0.99

BCL6 degradation caused by the interaction with the C-terminus of pro-HB-EGF induces cyclin D2 expression in gastric cancers. Br J Cancer (2009) 0.98

Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer. BMC Cancer (2009) 0.98

Chromatin modification and disease. J Med Genet (2000) 0.96

Computational and functional analysis of growth hormone (GH)-regulated genes identifies the transcriptional repressor B-cell lymphoma 6 (Bc16) as a participant in GH-regulated transcription. Endocrinology (2009) 0.94

PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells. Mol Cell Biol (2009) 0.94

A novel POK family transcription factor, ZBTB5, represses transcription of p21CIP1 gene. J Biol Chem (2009) 0.92

PLZF is a negative regulator of retinoic acid receptor transcriptional activity. Nucl Recept (2003) 0.90

Activation of the Notch-regulated transcription factor CBF1/RBP-Jkappa through the 13SE1A oncoprotein. Genes Dev (2001) 0.88

Cutting edge: T follicular helper cell differentiation is defective in the absence of Bcl6 BTB repressor domain function. J Immunol (2015) 0.87

The Drosophila BCL6 homolog Ken and Barbie promotes somatic stem cell self-renewal in the testis niche. Dev Biol (2012) 0.87

The novel BTB/POZ and zinc finger factor Zbtb45 is essential for proper glial differentiation of neural and oligodendrocyte progenitor cells. Cell Cycle (2010) 0.86

BACH2-BCL6 balance regulates selection at the pre-B cell receptor checkpoint. Trends Immunol (2013) 0.85

Epigenetic Regulation of the Blimp-1 Gene (Prdm1) in B Cells Involves Bach2 and Histone Deacetylase 3. J Biol Chem (2016) 0.83

The zinc finger transcription factor ZXDC activates CCL2 gene expression by opposing BCL6-mediated repression. Mol Immunol (2013) 0.82

Transcription factor effector domains. Subcell Biochem (2011) 0.81

Bcl6a function is required during optic cup formation to prevent p53-dependent apoptosis and colobomata. Hum Mol Genet (2013) 0.81

Functional interactions with Pit-1 reorganize co-repressor complexes in the living cell nucleus. J Cell Sci (2005) 0.80

Depudecin makes a debut. Proc Natl Acad Sci U S A (1998) 0.79

Interferon regulatory factor 8 (IRF8) interacts with the B cell lymphoma 6 (BCL6) corepressor BCOR. J Biol Chem (2014) 0.79

The ansamycin antibiotic, rifamycin SV, inhibits BCL6 transcriptional repression and forms a complex with the BCL6-BTB/POZ domain. PLoS One (2014) 0.78

Specific deficiency of Plzf paralog, Zbtb20, in Sertoli cells does not affect spermatogenesis and fertility in mice. Sci Rep (2014) 0.77

Human Kruppel-related 3 (HKR3) is a novel transcription activator of alternate reading frame (ARF) gene. J Biol Chem (2014) 0.77

Retinoid isomers differ in the ability to induce release of SMRT corepressor from retinoic acid receptor-alpha. J Biol Chem (1999) 0.77

Deficiency of the transcriptional repressor B cell lymphoma 6 (Bcl6) is accompanied by dysregulated lipid metabolism. PLoS One (2014) 0.77

Reciprocal occupancy of BCL6 and STAT5 on Growth Hormone target genes: contrasting transcriptional outcomes and promoter-specific roles of p300 and HDAC3. Mol Cell Endocrinol (2014) 0.76

trans repression of the human metallothionein IIA gene promoter by PZ120, a novel 120-kilodalton zinc finger protein. Mol Cell Biol (1999) 0.76

What Happens in the Thymus Does Not Stay in the Thymus: How T Cells Recycle the CD4+-CD8+ Lineage Commitment Transcriptional Circuitry To Control Their Function. J Immunol (2016) 0.76

Regulation of hematopoietic development by ZBTB transcription factors. Int J Hematol (2016) 0.75

Target acquisition and acute promyelocytic leukemia. J Clin Invest (1999) 0.75

Pits, a protein interacting with Ttk69 and Sin3A, has links to histone deacetylation. Sci Rep (2016) 0.75

AMPK Signaling Involvement for the Repression of the IL-1β-Induced Group IIA Secretory Phospholipase A2 Expression in VSMCs. PLoS One (2015) 0.75

Inhibition of the transcriptional repressor complex Bcl-6/BCoR induces endothelial sprouting but does not promote tumor growth. Oncotarget (2016) 0.75

The Relationship between RUVBL1 (Pontin, TIP49, NMP238) and BCL6 in Benign and Malignant Human Lymphoid Tissues. Biochem Biophys Rep (2016) 0.75

Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia. Oncotarget (2016) 0.75

The mTORC1-4E-BP-eIF4E axis controls de novo Bcl6 protein synthesis in T cells and systemic autoimmunity. Nat Commun (2017) 0.75

An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation. PLoS Pathog (2017) 0.75

Articles cited by this

A novel genetic system to detect protein-protein interactions. Nature (1989) 43.83

Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res (1992) 34.33

Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature (1995) 11.53

Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature (1978) 11.49

A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature (1995) 11.18

Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell (1997) 8.99

A vector for expressing GAL4(1-147) fusions in mammalian cells. Nucleic Acids Res (1989) 8.06

Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell (1997) 7.64

Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science (1997) 6.58

Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell (1997) 6.27

The POZ domain: a conserved protein-protein interaction motif. Genes Dev (1994) 5.96

Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell (1997) 5.83

The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet (1997) 5.55

Repression by Ume6 involves recruitment of a complex containing Sin3 corepressor and Rpd3 histone deacetylase to target promoters. Cell (1997) 5.07

Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell (1995) 4.98

Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature (1995) 3.90

Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science (1993) 3.89

An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell (1995) 3.68

Fusion between a novel Krüppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J (1993) 3.58

The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins. Cell Growth Differ (1995) 3.47

BCL-6 protein is expressed in germinal-center B cells. Blood (1995) 3.18

The tramtrack gene encodes a Drosophila finger protein that interacts with the ftz transcriptional regulatory region and shows a novel embryonic expression pattern. EMBO J (1990) 3.13

BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc Natl Acad Sci U S A (1996) 3.10

LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat Genet (1993) 2.49

Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood (1994) 2.38

Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma. Proc Natl Acad Sci U S A (1995) 2.13

SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc Natl Acad Sci U S A (1996) 2.04

Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. Mol Endocrinol (1996) 2.02

Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. EMBO J (1995) 1.94

Transcriptional repression by the proto-oncogene BCL-6. Oncogene (1996) 1.94

Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein. Proc Natl Acad Sci U S A (1996) 1.86

tramtrack is a transcriptional repressor required for cell fate determination in the Drosophila eye. Genes Dev (1993) 1.75

Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I Tax oncoprotein. Science (1996) 1.72

Alternatively spliced transcripts of the Drosophila tramtrack gene encode zinc finger proteins with distinct DNA binding specificities. EMBO J (1992) 1.70

The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain. Cell Growth Differ (1995) 1.68

The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivo. Oncogene (1995) 1.61

PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors. Proc Natl Acad Sci U S A (1994) 1.57

Gene involved in the 3q27 translocation associated with B-cell lymphoma, BCL5, encodes a Krüppel-like zinc-finger protein. Blood (1994) 1.36

Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states. Mol Cell Biol (1996) 1.32

Repression of Drosophila pair-rule segmentation genes by ectopic expression of tramtrack. Development (1993) 1.26

Control of myogenesis in the mouse myogenic C2 cell line by medium composition and by insulin: characterization of permissive and inducible C2 myoblasts. Differentiation (1988) 1.22

Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: results of rearrangement and gene expression studies and a mutational analysis of coding region sequences. Blood (1995) 1.21

Myf5, MyoD, myogenin and MRF4 myogenic derivatives of the embryonic mesenchymal cell line C3H10T1/2 exhibit the same adult muscle phenotype. Differentiation (1994) 1.20

Properties of initiator-associated transcription mediated by GAL4-VP16. Mol Cell Biol (1993) 1.13

Novel zinc finger proteins that interact with the mouse gamma F-crystallin promoter and are expressed in the sclerotome during early somitogenesis. Dev Biol (1994) 0.99

Multiple domains participate in distance-independent LAZ3/BCL6-mediated transcriptional repression. Biochem Biophys Res Commun (1996) 0.89

Small deletions occur in highly conserved regions of the LAZ3/BCL6 major translocation cluster in one case of non-Hodgkin's lymphoma without 3q27 translocation. Oncogene (1997) 0.86

All-trans- and 9-cis-retinoic acid inhibit growth of normal human and murine B cell precursors. J Immunol (1995) 0.86

Retinoids irreversibly inhibit in vitro growth of Epstein-Barr virus-immortalized B lymphocytes. Blood (1996) 0.84

Articles by these authors

The nuclear receptor superfamily: the second decade. Cell (1995) 24.99

The RXR heterodimers and orphan receptors. Cell (1995) 12.33

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell (1995) 11.72

A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature (1995) 11.18

The c-erb-A gene encodes a thyroid hormone receptor. Nature (1987) 10.53

PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell (1999) 10.08

Biochemical and genetic conservation of fission yeast Dsk1 and human SR protein-specific kinase 1. Mol Cell Biol (2000) 9.92

Coincidence of the promoter and capped 5' terminus of RNA from the adenovirus 2 major late transcription unit. Cell (1978) 9.60

Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell (1991) 9.40

Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell (1997) 8.99

Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell (1991) 8.85

Nuclear receptors and lipid physiology: opening the X-files. Science (2001) 8.76

Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell (1997) 8.72

Lariat structures are in vivo intermediates in yeast pre-mRNA splicing. Cell (1984) 8.71

Identification of a receptor for the morphogen retinoic acid. Nature (1988) 8.32

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell (1998) 7.91

Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature (1986) 7.81

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci U S A (1997) 7.52

Role of CBP/P300 in nuclear receptor signalling. Nature (1996) 7.36

The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature (1987) 7.06

9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell (1992) 6.75

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature (1992) 6.69

Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature (1982) 6.56

A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell (1994) 6.52

Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci U S A (1994) 6.46

Nuclear receptor that identifies a novel retinoic acid response pathway. Nature (1990) 6.23

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med (2001) 6.09

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell (1998) 5.78

Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature (1992) 5.76

A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell (2001) 5.76

Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA (2001) 5.74

Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature (1998) 5.63

Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell (1990) 5.59

Yeast mRNA splicing in vitro. J Biol Chem (1985) 5.48

Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell (1999) 5.23

Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature (1983) 5.20

LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev (1995) 4.93

A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes Dev (1998) 4.78

The initiation sites for RNA transcription in Ad2 DNA. Cell (1977) 4.76

Complex transcriptional units: diversity in gene expression by alternative RNA processing. Annu Rev Biochem (1986) 4.73

Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev (1992) 4.69

Functional domains of the human glucocorticoid receptor. Cell (1986) 4.68

Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell (1989) 4.56

Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist. Nature (1989) 4.47

A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature (1984) 4.35

Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science (1987) 4.32

A transcriptional switch mediated by cofactor methylation. Science (2001) 4.32

Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature (1982) 4.30

SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev (1998) 4.19

Translational control of C/EBPalpha and C/EBPbeta isoform expression. Genes Dev (2000) 4.06

Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell (1988) 4.00

Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Genes Dev (2000) 4.00

Identification of a nuclear receptor that is activated by farnesol metabolites. Cell (1995) 3.92

A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell (1991) 3.87

Identification of a new class of steroid hormone receptors. Nature (1988) 3.83

The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation. Nature (1990) 3.74

Terminal differentiation of human breast cancer through PPAR gamma. Mol Cell (1998) 3.71

Functional ecdysone receptor is the product of EcR and Ultraspiracle genes. Nature (1993) 3.71

Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell (1995) 3.70

Production of mRNA in Chinese hamster cells: relationship of the rate of synthesis to the cytoplasmic concentration of nine specific mRNA sequences. Cell (1979) 3.67

Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev (1996) 3.63

Colocalization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor. Cell (1987) 3.62

Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci U S A (1996) 3.57

RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev (1994) 3.54

The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins. Cell Growth Differ (1995) 3.47

Construction and identification by positive hybridization-translation of a bacterial plasmid containing a rat growth hormone structural gene sequence. Nucleic Acids Res (1978) 3.46

Retinoic acid and thyroid hormone induce gene expression through a common responsive element. Nature (1988) 3.42

Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature (2000) 3.41

Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev (1999) 3.41

A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell (1999) 3.36

Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature (1995) 3.32

Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature (1998) 3.23

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. Proc Natl Acad Sci U S A (1997) 3.22

Characterization of an autoregulated response element in the mouse retinoic acid receptor type beta gene. Proc Natl Acad Sci U S A (1990) 3.17

Drosophila ultraspiracle modulates ecdysone receptor function via heterodimer formation. Cell (1992) 3.14

Identification of a novel thyroid hormone receptor expressed in the mammalian central nervous system. Science (1987) 3.13

A repetitive DNA sequence, rhs, responsible for duplications within the Escherichia coli K-12 chromosome. J Mol Biol (1984) 3.00

Metal-ion coordination by U6 small nuclear RNA contributes to catalysis in the spliceosome. Nature (2000) 2.97

Activators of the nuclear receptor PPARgamma enhance colon polyp formation. Nat Med (1998) 2.90

Retinoic acid is a negative regulator of AP-1-responsive genes. Proc Natl Acad Sci U S A (1991) 2.85

Retinoid X receptor-COUP-TF interactions modulate retinoic acid signaling. Proc Natl Acad Sci U S A (1992) 2.85

An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci U S A (2001) 2.83

Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. Genes Dev (1994) 2.78

Identification of human glucocorticoid receptor complementary DNA clones by epitope selection. Science (1985) 2.77

Determinants for selective RAR and TR recognition of direct repeat HREs. Genes Dev (1993) 2.76

Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells. Science (1984) 2.75

Molecular consequences of specific intron mutations on yeast mRNA splicing in vivo and in vitro. Cell (1985) 2.75

A C/EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes. Mol Cell (1999) 2.73

Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell (1990) 2.68

Sharp, an inducible cofactor that integrates nuclear receptor repression and activation. Genes Dev (2001) 2.68

Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency. J Clin Invest (2000) 2.67

The purified yeast pre-mRNA splicing factor PRP2 is an RNA-dependent NTPase. EMBO J (1992) 2.60

The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev (1998) 2.58

Splice commitment dictates neuron-specific alternative RNA processing in calcitonin/CGRP gene expression. Cell (1987) 2.58

Differential activation of adipogenesis by multiple PPAR isoforms. Genes Dev (1996) 2.58

Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev (1999) 2.57

LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat Genet (1993) 2.49